Danmark -
dansk -
SEGES Landbrug & Fødevarer
predict flydende middel
nordisk alkali - penetreringsolie - flydende middel - 1000 g/l penetreringsolie
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
solymbic
amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - immunosuppressiva - se venligst afsnit 4. 1 i resuméet af produktegenskaber i produktinformationsdokumentet.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
elektrolyt "sad" infusionsvæske, opløsning
amgros i/s - calciumchloriddihydrat, glucosemonohydrat, kaliumchlorid, kobberacetatmonohydrat, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid, natriumiodid, zinkacetatdihydrat - infusionsvæske, opløsning
Danmark -
dansk -
SEGES Landbrug & Fødevarer
sun-oil 33 e flydende middel
klarsø a/s - mineralsk, penetreringsolie - flydende middel - 1000 g/l mineralsk penetreringsolie ; (~ 1.000 g/l penetreringsolie
Danmark -
dansk -
SEGES Landbrug & Fødevarer
sun-oil 11 e flydende middel
manglende oplysninger - mineralsk, penetreringsolie - flydende middel - 1000 g/l mineralsk penetreringsolie ; (~ 1.000 g/l penetreringsolie
Danmark -
dansk -
SEGES Landbrug & Fødevarer
harmony 50 sx vandopløseligt granulat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - thifensulfuron-methyl, thifensulfuron - vandopløseligt granulat - 500 g/kg thifensulfuron-methyl ; (~ 482 g/kg thifensulfuron)
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiske midler - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.